close
MENU
Hot Topic Hawke’s Bay
Hot Topic Hawke’s Bay
Investment
1 mins to read

A2 Milk plays down US approval reports

The company went into a trading halt late Tuesday following a media report.

A2 hopes to get US Food and Drug Administration (FDA) to allow it to sell baby formula into the United States.

NBR Staff Tue, 02 Aug 2022

A2 Milk has played down a media report today which suggested the company was nearing approval from the US Food and Drug Administration (FDA) to allow it to sell baby formula into that market.

The announcement came shortly after the NZX's regulatory arm, NZ RegCo, placed a trading halt at 4.29pm

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
NBR Staff Tue, 02 Aug 2022
Contact the Writer: editor@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
A2 Milk plays down US approval reports
Investment,
95113
true